Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01483196 : Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Patients must have histologically or cytologically confirmed non-metastatic breast
cancer; stages 1-3 are acceptable

- Patients must be candidates for either neoadjuvant or adjuvant chemotherapy for
breast cancer

- Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

- Patients who have had prior systemic chemotherapy are not eligible for the study

- Patients who are scheduled to receive trastuzumab and/or bevacizumab are not eligible

- Patients who are on dialysis

- Women who are pregnant are not eligible due to unknown risks and potential harm to
the unborn fetus

- Patients with metastatic breast cancer are not eligible
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557